NASEM report offers strategies to make prescription drugs more affordable

Nov 30, 2017 - 09:17 AM

Access to effective and affordable medicines is necessary for public health, social equity, and economic development, but the biopharmaceutical sector is not meeting that need, according to a report released today by the National Academies of Sciences, Engineering, and Medicine. “Our report seeks to address the market failures that currently permeate the biopharmaceutical sector, such as lack of competition due to distortions in the application of the patent protection process, the imbalance between the negotiating power of suppliers and purchasers, and the convoluted structure of the supply chain,” the authors note. The report offers eight recommendations with 27 actions to improve the affordability of prescription drugs without discouraging the development of new and more effective drugs for the future. Among other measures, the report recommends improving methods for assessing the value that drugs provide and ensuring that incentives to develop drugs for rare diseases are not extended to widely sold drugs; taking actions to continually foster greater access to off-patent generic drugs; and discouraging direct-to-consumer advertisements for prescription drugs. 

Related News Articles

Headline
CMS notifies states of options for transitioning to 6-month Medicaid renewals
The Centers for Medicare & Medicaid Services March 6 issued guidance to states on transitioning to six-month Medicaid redeterminations in 2027, a change…
Headline
House E&C Committee leaders expand Medicaid fraud investigation
Republican leaders on the House Committee on Energy and Commerce March 5 announced they were expanding their ongoing investigation into waste, fraud and abuse…
Headline
CMS issues toolkit on behavioral health services for children in Medicaid, CHIP
The Centers for Medicare & Medicaid Services has released a toolkit that outlines strategies for states to strengthen access to behavioral health services…
Headline
CMS announces actions addressing fraud
The Centers for Medicare & Medicaid Services Feb. 25 released a request for information on potential regulatory changes in a possible future…
Headline
AHA comments to CMS on GLOBE payment model
The AHA commented today on the Centers for Medicare & Medicaid Services’ proposed rule on the Global Benchmark for Efficient Drug Pricing Model, or…
Headline
AHA submits comments on CMS proposed rule on prohibiting ‘sex-rejecting procedures’ for children
The AHA Feb. 17 submitted a comment letter responding to the Centers for Medicare & Medicaid Services’ proposed rule that would prohibit hospitals…